Gasherbrum Bio Inc. has patented new heterocyclic glucagon-like peptide 1 receptor (GLP-1R) agonists reported to be useful for the treatment of type 2 diabetes, among others.

Treatment options for patients with moderately to severely active Crohn's disease have expanded in the past decade, with ...

Long-term obesity is associated with the expression of biomarkers denoting antagonistic and integrative aging hallmarks in adults aged 28 to 31 years, according to a study published online July 11 in ...

Managing type 1 diabetes has a substantial impact on quality of life and psychological health. Indeed, insulin overdosing can ...

Type 1 diabetes is more prevalent in Finland than anywhere else in the world, affecting approximately 50,000 people.

AbbVie has acquired global rights to the lead pipeline asset of Ichnos Glenmark Innovation (IGI), the cancer and autoimmune disease candidate ISB 2001, through an exclusive licensing agreement that ...

A professor of physiological nursing explains the differences between genetic predisposition and lifestyle factors for type 2 ...

Type 1 diabetes is more prevalent in Finland than anywhere else in the world, affecting approximately 50,000 people. New ...

The infamous Keto diet was named after it – here’s what actually happens to your body when you achieve ketosis ...

Acromegaly is a rare, chronic endocrine disorder characterized by excessive secretion of growth hormone (GH), most commonly resulting from a benign pituitary adenoma.

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is), originally developed for type 2 diabetes treatment, have demonstrated in randomised ...

Women who developed a cardiovascular disease or type 2 diabetes were at a higher risk of developing breast cancer post ...